These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 14503806)
1. Clinical significance of AIB1 expression in human breast cancer. Iwase H; Omoto Y; Toyama T; Yamashita H; Hara Y; Sugiura H; Zhang Z Breast Cancer Res Treat; 2003 Aug; 80(3):339-45. PubMed ID: 14503806 [TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome. Harigopal M; Heymann J; Ghosh S; Anagnostou V; Camp RL; Rimm DL Breast Cancer Res Treat; 2009 May; 115(1):77-85. PubMed ID: 18521745 [TBL] [Abstract][Full Text] [Related]
3. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients. Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282 [TBL] [Abstract][Full Text] [Related]
4. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. Bautista S; Vallès H; Walker RL; Anzick S; Zeillinger R; Meltzer P; Theillet C Clin Cancer Res; 1998 Dec; 4(12):2925-9. PubMed ID: 9865902 [TBL] [Abstract][Full Text] [Related]
5. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells. Su Q; Hu S; Gao H; Ma R; Yang Q; Pan Z; Wang T; Li F Oncology; 2008; 75(3-4):159-68. PubMed ID: 18827493 [TBL] [Abstract][Full Text] [Related]
6. Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue. Haugan Moi LL; Hauglid Flågeng M; Gandini S; Guerrieri-Gonzaga A; Bonanni B; Lazzeroni M; Gjerde J; Lien EA; DeCensi A; Mellgren G Clin Cancer Res; 2010 Apr; 16(7):2176-86. PubMed ID: 20332317 [TBL] [Abstract][Full Text] [Related]
7. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer. Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532 [TBL] [Abstract][Full Text] [Related]
8. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen. Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393 [TBL] [Abstract][Full Text] [Related]
9. AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Planas-Silva MD; Shang Y; Donaher JL; Brown M; Weinberg RA Cancer Res; 2001 May; 61(10):3858-62. PubMed ID: 11358796 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer. Dihge L; Bendahl PO; Grabau D; Isola J; Lövgren K; Rydén L; Fernö M Breast Cancer Res Treat; 2008 May; 109(2):255-62. PubMed ID: 17636398 [TBL] [Abstract][Full Text] [Related]
11. Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma. Heck S; Rom J; Thewes V; Becker N; Blume B; Sinn HP; Deuschle U; Sohn C; Schneeweiss A; Lichter P Cancer Res; 2009 Jun; 69(12):5186-93. PubMed ID: 19491275 [TBL] [Abstract][Full Text] [Related]
12. Altered expression of estrogen receptor coregulators during human breast tumorigenesis. Murphy LC; Simon SL; Parkes A; Leygue E; Dotzlaw H; Snell L; Troup S; Adeyinka A; Watson PH Cancer Res; 2000 Nov; 60(22):6266-71. PubMed ID: 11103781 [TBL] [Abstract][Full Text] [Related]
13. Expression of nuclear receptors and cofactors in human endometrium and myometrium. Vienonen A; Miettinen S; Bläuer M; Martikainen PM; Tomás E; Heinonen PK; Ylikomi T J Soc Gynecol Investig; 2004 Feb; 11(2):104-12. PubMed ID: 14980312 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Bouras T; Southey MC; Venter DJ Cancer Res; 2001 Feb; 61(3):903-7. PubMed ID: 11221879 [TBL] [Abstract][Full Text] [Related]
15. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363 [TBL] [Abstract][Full Text] [Related]
16. A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells. Lauritsen KJ; List HJ; Reiter R; Wellstein A; Riegel AT Oncogene; 2002 Oct; 21(47):7147-55. PubMed ID: 12370804 [TBL] [Abstract][Full Text] [Related]
17. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy. Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229 [TBL] [Abstract][Full Text] [Related]
18. HDAC6 expression is correlated with better survival in breast cancer. Zhang Z; Yamashita H; Toyama T; Sugiura H; Omoto Y; Ando Y; Mita K; Hamaguchi M; Hayashi S; Iwase H Clin Cancer Res; 2004 Oct; 10(20):6962-8. PubMed ID: 15501975 [TBL] [Abstract][Full Text] [Related]
19. Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue. List HJ; Reiter R; Singh B; Wellstein A; Riegel AT Breast Cancer Res Treat; 2001 Jul; 68(1):21-8. PubMed ID: 11678305 [TBL] [Abstract][Full Text] [Related]
20. Tamoxifen induces heparanase expression in estrogen receptor-positive breast cancer. Cohen I; Maly B; Simon I; Meirovitz A; Pikarsky E; Zcharia E; Peretz T; Vlodavsky I; Elkin M Clin Cancer Res; 2007 Jul; 13(14):4069-77. PubMed ID: 17634531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]